[Anti-tumor effect of glutacyt 2 in leukemia L1210 at different sites].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy; D005260:Female; D005977:Glutarates / Q000627:therapeutic use*; D006824:Hybridization, Genetic; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D010534:Peritoneal Neoplasms / Q000188:drug therapy; D012983:Soft Tissue Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D005977:Glutarates; C049679:glutacyt2
Protivotumoren efekt na glutatsit 2 pri levkoza L1210 s razlichna lokalizatsiia.